Mednet Logo
HomePediatric Hematology/OncologyQuestion

How do you approach a patient with newly diagnosed high-grade osteosarcoma who received maximum cumulative dose of doxorubicin for a soft tissue sarcoma 10 years earlier?

1
2 Answers
Mednet Member
Mednet Member
Medical Oncology · Emory University

Some chemo is better than no chemo for osteosarcoma.

That is what is known. After the first randomized study establishing that chemo was effective at improving survival for OS, all subsequent randomized studies have been statistical ties. No regimen or schedule or dose or drug has been proven to be b...

Register or Sign In to see full answer

Mednet Member
Mednet Member
Pediatric Hematology/Oncology · Maria Fareri Children’s Hospital

In planning for treatment for your patient, you might consider the following articles.

  1. Anninga et al., PMID 21703851 - Of cisplatin, ifosfamide, doxorubicin, methotrexate, and etoposide, using 3 chemotherapeutic agents is better than 2, but 4 isn't better than 3 in treating osteosarcoma. Etoposide i...

Register or Sign In to see full answer

How do you approach a patient with newly diagnosed high-grade osteosarcoma who received maximum cumulative dose of doxorubicin for a soft tissue sarcoma 10 years earlier? | Mednet